- PRICING
- LIVE QUOTES
- LEARN
- HELP
EN
1 Value Stock to Target This Week and 2 That Underwhelm
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason, and a low valuation can reflect underlying business challenges rather than a genuine bargain.
Separating the winners from the value traps is a tough challenge, and that’s where StockStory comes in. Our job is to find you high-quality companies that will stand the test of time. Keeping that in mind, here is one value stock trading at a big discount to its intrinsic value and two with little support.
Two Value Stocks to Sell:
GoodRx (GDRX)
Forward P/E Ratio: 10.1x
Started in 2011 to tackle the problem of high prescription drug costs in America, GoodRx (NASDAQ:GDRX) operates a digital platform that helps consumers find lower prices on prescription medications through price comparison tools and discount codes.
Why Do We Think GDRX Will Underperform?
- Flat sales over the last two years suggest it must find different ways to grow during this cycle
- Smaller revenue base of $785.2 million means it hasn’t achieved the economies of scale that some industry juggernauts enjoy
- ROIC of -0.4% reflects management’s challenges in identifying attractive investment opportunities
GoodRx’s stock price of $3.31 implies a valuation ratio of 10.1x forward P/E. To fully understand why you should be careful with GDRX, check out our full research report (it’s free).
Everforth (EFOR)
Forward P/E Ratio: 8.4x
Evolving from its roots in IT staffing to become a high-end technology consulting powerhouse, Everforth (EFOR) provides specialized IT consulting services and staffing solutions to Fortune 1000 companies and U.S. federal government agencies.
Why Are We Out on EFOR?
- Annual sales declines of 3.7% for the past two years show its products and services struggled to connect with the market during this cycle
- Demand will likely be weak over the next 12 months as Wall Street expects flat revenue
- Earnings per share have dipped by 4.3% annually over the past five years, which is concerning because stock prices follow EPS over the long term
At $32.84 per share, Everforth trades at 8.4x forward P/E. If you’re considering EFOR for your portfolio, see our FREE research report to learn more.
One Value Stock to Watch:
CarGurus (CARG)
Forward EV/EBITDA Ratio: 8x
Bringing transparency to a sometimes opaque process, CarGurus (NASDAQ:CARG) is a digital marketplace where auto dealers can connect with potential customers and where car buyers can browse, purchase, and obtain financing.
Why Could CARG Be a Winner?
- Platform is difficult to replicate at scale and leads to a best-in-class gross margin of 90.1%
- Earnings per share grew by 35.5% annually over the last three years, massively outpacing its peers
- Strong free cash flow margin of 28.6% enables it to reinvest or return capital consistently, and its improved cash conversion implies it’s becoming a less capital-intensive business
CarGurus is trading at $30.81 per share, or 8x forward EV/EBITDA. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.